Funding

Olympus Corporation has committed $150m to a new venture capital (VC) fund, aiming to deploy the capital to promising medtech startups in the gastrointestinal...

Subsense, a developer of non-surgical invasive, nanoparticle-based brain-computer interfaces (BCIs), has added $10 million in new capital following positive early breakthroughs, bringing total funding...

Impulse Dynamics announced that it raised more than $158 million in financing to support its heart failure treatment technology. New institutional investors, including Sands Capital...

Saluda Medical announced that it raised $150 million through an initial public offering on the Australian Securities Exchange (ASX). Minneapolis-based Saluda raised A$230.8 million through...

Mirai Medical, the lead applicant and coordinating partner, has been awarded €7.2M under the Disruptive Technologies Innovation Fund (DTIF) Call 7 for PIONEER -...

Kestra Medical Technologies announced that it priced an upsized underwritten offering worth approximately $138 million. The Kirkland, Washington-based company said its offering includes 6 million...

VisCardia, a medical device company pioneering a novel cardiac-support therapy for patients with heart failure, announced it has secured $40 million in growth financing...

Spurred by a positive clinical trial readout recently, Xeltis has raised €47.5m ($55.1m) to advance commercialisation efforts for aXess, a vascular access implant graft...

Akura Medical, a Shifamed portfolio company, announced that it completed the first close of its Series C financing, raising $53 million. Los Gatos, California-based Akura...